IL129135A0 - 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds - Google Patents
3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compoundsInfo
- Publication number
- IL129135A0 IL129135A0 IL12913597A IL12913597A IL129135A0 IL 129135 A0 IL129135 A0 IL 129135A0 IL 12913597 A IL12913597 A IL 12913597A IL 12913597 A IL12913597 A IL 12913597A IL 129135 A0 IL129135 A0 IL 129135A0
- Authority
- IL
- Israel
- Prior art keywords
- alkoxyisoxazol
- substituted
- carboxylic acid
- acid compounds
- amino carboxylic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK109296 | 1996-10-04 | ||
| PCT/DK1997/000426 WO1998015542A1 (en) | 1996-10-04 | 1997-10-03 | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL129135A0 true IL129135A0 (en) | 2000-02-17 |
Family
ID=8100908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12913597A IL129135A0 (en) | 1996-10-04 | 1997-10-03 | 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6200999B1 (xx) |
| EP (1) | EP0934286B1 (xx) |
| JP (1) | JP2001501630A (xx) |
| KR (1) | KR20000048908A (xx) |
| CN (1) | CN1238766A (xx) |
| AR (1) | AR008880A1 (xx) |
| AT (1) | ATE230734T1 (xx) |
| AU (1) | AU733004B2 (xx) |
| BG (1) | BG103348A (xx) |
| BR (1) | BR9712198A (xx) |
| CA (1) | CA2268028C (xx) |
| CZ (1) | CZ116899A3 (xx) |
| DE (1) | DE69718338T2 (xx) |
| EA (1) | EA001625B1 (xx) |
| ES (1) | ES2189978T3 (xx) |
| HU (1) | HUP0000084A3 (xx) |
| IL (1) | IL129135A0 (xx) |
| IS (1) | IS5009A (xx) |
| NO (1) | NO312961B1 (xx) |
| NZ (1) | NZ334798A (xx) |
| PL (1) | PL332553A1 (xx) |
| SK (1) | SK42899A3 (xx) |
| TR (1) | TR199900724T2 (xx) |
| UA (1) | UA52698C2 (xx) |
| WO (1) | WO1998015542A1 (xx) |
| ZA (1) | ZA978877B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73749C2 (en) * | 1999-11-01 | 2005-09-15 | Diarylenines | |
| US6495582B1 (en) * | 2000-09-15 | 2002-12-17 | Vertex Pharmaceuticals Incorporated | Isoxazole compositions useful as inhibitors of ERK |
| US20040106794A1 (en) * | 2001-04-16 | 2004-06-03 | Schering Corporation | 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| UA78529C2 (en) * | 2001-10-10 | 2007-04-10 | Wyeth Corp | Derivatives of [[2-(amino-3,4-dioxo-1-cyclobutene-1-yl)amino]alkyl] acid for treating pain |
| US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
| CN1863810B (zh) | 2003-04-09 | 2010-12-01 | 惠氏公司 | [2-(8，9-二氧代-2，6-二氮杂二环[5.2.0]壬-1(7)-烯-2-基)烷基]膦酸衍生物及其作为n-甲基-d-天冬氨酸(nmda)受体拮抗剂的应用 |
| TW200514775A (en) | 2003-10-22 | 2005-05-01 | Wyeth Corp | Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl} phosphonic acid and esters thereof |
| CN101277952B (zh) * | 2005-10-11 | 2011-09-28 | 弗·哈夫曼-拉罗切有限公司 | 异*唑衍生物 |
| WO2009092324A1 (en) * | 2008-01-16 | 2009-07-30 | Hong Kong University Of Science And Technology | Oxazolidine derivatives as nmda antagonists |
| EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
| TW201609719A (zh) * | 2014-05-28 | 2016-03-16 | 美國禮來大藥廠 | 作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物 |
| US10442768B2 (en) | 2016-01-21 | 2019-10-15 | Agro-Kanesho Co., Ltd. | Method for producing 2-aminonicotinic acid benzyl ester derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0456519T3 (da) | 1990-05-11 | 1994-11-07 | Sankyo Co | Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelse |
| DE69325662T2 (de) | 1992-10-23 | 2000-02-10 | Merck Sharp & Dohme Ltd., Hoddesdon | Dopamin rezeptor subtyp liganden |
| DK124393D0 (da) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
-
1997
- 1997-03-10 UA UA99042300A patent/UA52698C2/uk unknown
- 1997-10-03 WO PCT/DK1997/000426 patent/WO1998015542A1/en not_active Application Discontinuation
- 1997-10-03 KR KR1019990702938A patent/KR20000048908A/ko not_active Application Discontinuation
- 1997-10-03 SK SK428-99A patent/SK42899A3/sk unknown
- 1997-10-03 EA EA199900358A patent/EA001625B1/ru not_active IP Right Cessation
- 1997-10-03 TR TR1999/00724T patent/TR199900724T2/xx unknown
- 1997-10-03 NZ NZ334798A patent/NZ334798A/en unknown
- 1997-10-03 DE DE69718338T patent/DE69718338T2/de not_active Expired - Fee Related
- 1997-10-03 BR BR9712198-3A patent/BR9712198A/pt unknown
- 1997-10-03 CN CN97180167A patent/CN1238766A/zh active Pending
- 1997-10-03 AR ARP970104586A patent/AR008880A1/es not_active Application Discontinuation
- 1997-10-03 ZA ZA9708877A patent/ZA978877B/xx unknown
- 1997-10-03 ES ES97942821T patent/ES2189978T3/es not_active Expired - Lifetime
- 1997-10-03 US US09/269,356 patent/US6200999B1/en not_active Expired - Fee Related
- 1997-10-03 HU HU0000084A patent/HUP0000084A3/hu unknown
- 1997-10-03 PL PL97332553A patent/PL332553A1/xx unknown
- 1997-10-03 EP EP97942821A patent/EP0934286B1/en not_active Expired - Lifetime
- 1997-10-03 CZ CZ991168A patent/CZ116899A3/cs unknown
- 1997-10-03 AU AU44517/97A patent/AU733004B2/en not_active Ceased
- 1997-10-03 AT AT97942821T patent/ATE230734T1/de not_active IP Right Cessation
- 1997-10-03 JP JP10517096A patent/JP2001501630A/ja active Pending
- 1997-10-03 CA CA002268028A patent/CA2268028C/en not_active Expired - Fee Related
- 1997-10-03 IL IL12913597A patent/IL129135A0/xx unknown
-
1999
- 1999-03-20 BG BG103348A patent/BG103348A/xx unknown
- 1999-03-23 IS IS5009A patent/IS5009A/is unknown
- 1999-03-30 NO NO19991561A patent/NO312961B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001501630A (ja) | 2001-02-06 |
| DE69718338D1 (de) | 2003-02-13 |
| UA52698C2 (uk) | 2003-01-15 |
| AU733004B2 (en) | 2001-05-03 |
| BR9712198A (pt) | 1999-08-31 |
| CN1238766A (zh) | 1999-12-15 |
| IS5009A (is) | 1999-03-23 |
| ZA978877B (en) | 1998-04-17 |
| ES2189978T3 (es) | 2003-07-16 |
| EP0934286A1 (en) | 1999-08-11 |
| NO991561D0 (no) | 1999-03-30 |
| EA001625B1 (ru) | 2001-06-25 |
| BG103348A (en) | 1999-11-30 |
| WO1998015542A1 (en) | 1998-04-16 |
| EP0934286B1 (en) | 2003-01-08 |
| NZ334798A (en) | 2000-06-23 |
| HUP0000084A3 (en) | 2001-12-28 |
| CA2268028C (en) | 2003-03-18 |
| DE69718338T2 (de) | 2003-10-16 |
| NO312961B1 (no) | 2002-07-22 |
| ATE230734T1 (de) | 2003-01-15 |
| PL332553A1 (en) | 1999-09-13 |
| HUP0000084A2 (hu) | 2000-06-28 |
| NO991561L (no) | 1999-06-04 |
| KR20000048908A (ko) | 2000-07-25 |
| CZ116899A3 (cs) | 1999-09-15 |
| EA199900358A1 (ru) | 1999-10-28 |
| US6200999B1 (en) | 2001-03-13 |
| SK42899A3 (en) | 1999-08-06 |
| TR199900724T2 (xx) | 1999-06-21 |
| CA2268028A1 (en) | 1998-04-16 |
| AU4451797A (en) | 1998-05-05 |
| AR008880A1 (es) | 2000-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9626637D0 (en) | Percarboxyilic acid solutions | |
| HU9801045D0 (en) | Substituted diamino-carboxylic acids | |
| HU9801044D0 (en) | Sulfonyl-amino-carboxylic acid derivatives | |
| HUP0003881A3 (en) | Amidocarboxylic acid derivatives | |
| HUP9902645A3 (en) | Fused-ring carboxylic acid derivatives | |
| HUP0600401A3 (en) | Naphtyridine carboxylic acid derivative salt | |
| EP0801644A4 (en) | POLYARYLCARBAMOYLAZADIOQUE ACIDS AND CARBAMOYLALCANEDIO QUES | |
| ZA9810298B (en) | Isothiazole carboxylic acid derivatives | |
| NZ286622A (en) | Fluorophenylalkenylcarboxylic acid guanidides | |
| IL129135A0 (en) | 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds | |
| HU9500728D0 (en) | 5-vinyl- and 5-ethinyl-quinolon- and -naphtiridone-carboxylig acids | |
| EP0774965A4 (en) | PHENOXYPHENYLACETIC ACID DERIVATIVES | |
| HU9503309D0 (en) | Carboxylic acid amide benzothiophene-s-oxides | |
| IL135967A0 (en) | Jasmonic acid compounds and process for the preparation thereof | |
| HU9601167D0 (en) | 5-arylisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
| ZA9510888B (en) | 3-aryl-tetronic acid derivatives | |
| ZA981472B (en) | Process for the manufacture of carboxylic acids | |
| GB9426261D0 (en) | Clavulanic acid salts | |
| IL123213A0 (en) | Carboxylic acid derivatives | |
| HU9700148D0 (en) | Trifluoromethylquinolinecarboxylic acid derivative | |
| IL135639A0 (en) | Novel methylenebisphosphonic acid derivatives | |
| SI0934286T1 (en) | 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds | |
| ZA956017B (en) | Heterocyclyl-1-phenyl-substituted quinolonecarboxylic acids | |
| AU5319898A (en) | Glyoxylic acid amides | |
| AU8214498A (en) | Glyoxylic acid amides |